Invadopodia-Related Proteins Expression in Mucoepidermoid Carcinoma. A systematic review.
DOI:
https://doi.org/10.51168/sjhrafrica.v4i6.2523Keywords:
Mucoepidermoid carcinoma, Invadopodia, Tyrosine kinase substrate 4 (Tks4), Tyrosine kinase substrate 5 (Tks5), Cortactin, Membrane type 1 matrix metalloproteinase (MT1-MMP), Matrix metalloproteinase 2 (MMP-2), Matrix metalloproteinase 9 (MMP-9), MetallothioneinAbstract
Background
Mucoepidermoid carcinoma (MEC) is the most common malignant salivary gland tumor, displaying wide biological heterogeneity from indolent low-grade lesions to aggressive high-grade variants. Invadopodia are specialized actin-rich protrusions that degrade the extracellular matrix (ECM) and facilitate invasion. Core proteins such as Tks4, Tks5, cortactin and MT1-MMP, together with matrix metalloproteinases (MMP-2/9), have been implicated in invasion in several carcinomas, but their role in MEC has only recently been examined.
Objective: To systematically evaluate the expression of invadopodia-related proteins in MEC and their contribution to tumor invasiveness.
Methods
This review was conducted in accordance with PRISMA 2020 guidelines and the protocol was prospectively registered in PROSPERO (Registration ID: CRD420251152863). A comprehensive search of PubMed, Embase, Scopus and Web of Science was performed up to September 2025. Original studies analyzing invadopodia-related proteins in MEC were included. Data extraction covered study design, sample size, proteins evaluated, methodology and outcomes. Risk of bias was assessed using Joanna Briggs Institute (JBI) tools for tissue studies and an adapted appraisal framework for in vitro studies.
Results
Six studies met the inclusion criteria from 57 screened records. Immunohistochemistry demonstrated overexpression of Tks4, Tks5, cortactin and MT1-MMP in MEC compared with normal salivary glands. Functional silencing of Tks4/Tks5 reduced invadopodia formation, ECM degradation and cell invasiveness. MT1-MMP localized to carcinoma membranes and activated pro-MMP-2, while metallothionein enhanced invasiveness by modulating MMP-2/9. Clear-cell MEC also showed MMP-2 positivity on immunoarray analysis.
Conclusions
Invadopodia-related proteins are consistently expressed in MEC and appear to play a central role in its invasive phenotype. Larger multicenter studies with standardized protocols and integration of clinical outcomes are needed to establish their prognostic value and explore therapeutic potential.
References
Sama S, Komiya T, Guddati AK. Advances in the Treatment of Mucoepidermoid Carcinoma. World J Oncol. 2022 Feb;13(1):1-7.
Mago A. Mucoepidermoid Carcinoma: Presentation at an Uncommon Site. J Med Sci 2020;6(3):51-53.
Fehr A, Werenicz S, Trocchi P, et al. Mucoepidermoid carcinoma of the salivary glands revisited with special reference to histologic grading and CRTC1/3-MAML2 genotyping. Virchows Arch. 2021 Nov;479(5):975-985.
Cipriani NA, Lusardi JJ, McElherne J, et al. Mucoepidermoid Carcinoma: A Comparison of Histologic Grading Systems and Relationship to MAML2 Rearrangement and Prognosis. Am J Surg Pathol. 2019 Jul;43(7):885-897.
Hao Z, Zhang M, Du Y, et al. Invadopodia in cancer metastasis: dynamics, regulation and targeted therapies. J Transl Med. 2025 May 16;23(1):548.
Paz H, Pathak N, Yang J. Invading one step at a time: the role of invadopodia in tumor metastasis. Oncogene. 2014 Aug 14;33(33):4193-202.
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021 Mar 29;372:n71.
Amir-Behghadami M, Janati A. Population, Intervention, Comparison, Outcomes and Study (PICOS) design as a framework to formulate eligibility criteria in systematic reviews. Emerg Med J. 2020 Jun;37(6):387.
Loureiro FJA, Balbinot KM, da Silva Kataoka MS, et al. Invadopodia Related-Proteins Expression in Mucoepidermoid Carcinoma. Oral Dis. 2025 Aug;31(8):2427-2440.
Thaianna Lima De Oliveira, Felippe José Almeida Loureiro, Karolyny Martins Balbinot, et al. Cross-talk of proteins related to invadopodia and the invasion process in salivary gland mucoepidermoid carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2022;134(3):e218-e219.
Felippe José Almeida Loureiro, Karolyny Martins Balbinot, Thaianna Lima De Oliveira, et al. Tyrosine kinase proteins Tks4 and Tks5 participate in the invasiveness of salivary gland mucoepidermoid carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2022;134(3):e207-e208.
Aquime JRHS, Zampieri LCDP, Kataoka MSDS, et al. Metallothionein Expression and its Influence on the In Vitro Biological Behavior of Mucoepidermoid Carcinoma. Cells. 2020 Jan 8;9(1):157.
Yeon Sook Kim, Sang Shin Lee, Ji Yong Song, et al. Immunohistochemical Array for Clear Cell Type Mucoepidermoid Carcinoma. Journal of Pathology and Translational Medicine. 2010;44(3):284-294.
Kayano K, Shimada T, Shinomiya T, et al. Activation of pro-MMP-2 mediated by MT1-MMP in human salivary gland carcinomas: possible regulation of pro-MMP-2 activation by TIMP-2. J Pathol. 2004;202(4):403-411.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Dr. Karthik Shunmugavelu, Dr. Niraimathi Gnanasekaran

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
















